The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase Ib/II study of neoadjuvant chemoradiotherapy with CRLX101 and capecitabine for locally advanced rectal cancer.
 
Andrew Wang
Stock and Other Ownership Interests - Capio BioSciences
Research Funding - Accuray
Patents, Royalties, Other Intellectual Property - Biomatrix patent licensed to PhoenixSongs
 
Autumn Jackson McRee
No Relationships to Disclose
 
A. William Blackstock
No Relationships to Disclose
 
Bert H. O'Neil
Consulting or Advisory Role - Amgen; Bayer; Genentech/Roche; Lilly/ImClone
Travel, Accommodations, Expenses - Merck KGaA
 
Dominic T. Moore
No Relationships to Disclose
 
Benjamin F. Calvo
No Relationships to Disclose
 
Michael Sangmin Lee
No Relationships to Disclose
 
Curran Murphy
Employment - Cerulean Pharma
 
Kim Caliri
Employment - Cerulean Pharma
Leadership - Cerulean Pharma
Stock and Other Ownership Interests - Cerulean Pharma
 
Maureen T. Tynan
No Relationships to Disclose
 
Adrian Mario Senderowicz
Employment - Cerulean Pharma
Leadership - Cerulean Pharma
Stock and Other Ownership Interests - Cerulean Pharma
 
Joel E. Tepper
Consulting or Advisory Role - EMD Serono
 
Hanna Kelly Sanoff
Research Funding - Bayer (Inst); Immunomedics (Inst); Merck (Inst); Novartis (Inst); Precision Biologics (Inst)